New Research: From cereus to anthrax and back again: Assessment of the temperature-dependent phenotypic switching in the “cross-over” strain Bacillus cereus G9241 https://t.co/hVNsP2wJmo #microbiology
Really interesting interactive audience & speaker panel discussion chaired by BactiVac Advisory Board member Peter Borriello. Lots interesting points being raised about the challenges faced in developing bacterial vaccines for veterinary infections in both high income and low income country settings.
#BactiVacEvents #IVIS2025 #AMR
@wellcometrust@The_MRC@UKgovGHS@UoBinfectionsch
Welcome our postdoc Shathviga Manoharan from Cambridge Uni in @MucosalSwineflu and @Pirbright_Inst.
@Shathviga will be working to develop a broadly cross-reactive vaccines that will protect human against influenza.
Applications for 2025 entry to the Warwick MRC DTP in IBR Programme are now open! Please click the link below for more details:
https://t.co/bYBfD7qM9C
Hello! As I mentioned before, we have a few more roles now open at NanoSyrinx:
🧬 Protein engineering/platform dev Scientist II/Senior Scientist
👩🔬 Senior Scientist (Protein Production)
🥽 Lab Ops Assistant/Technician
You can find them all at:
https://t.co/JyHlVHDoCF
The flu vaccine helps protect against influenza, a common and highly infectious virus. It’s free for eligible individuals or available privately at most pharmacies. Get vaccinated early to ensure you’re protected sooner.
Learn more on Vaccine Knowledge: https://t.co/ZJS5k5ZabT
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Extremely happy to see this paper out!
Building from our previous work (see https://t.co/73NdynQcPh), we have looked into exploiting outer membrane vesicles from Neisseria cinerea to express multiple meningococcal antigens.
https://t.co/KZ7FjI1HEc
Over the last week, this year’s cohort Bio-Spark challenge-solving fellows presented their findings to company partners and the rest of the cohort. Join us tomorrow at 19:00 at @TheLabCambridge to find out more about the programme!
Secure your spot here: https://t.co/x3wiOkgWtU
Glad to see our lipase/FAME story out @CommsBio after constructive peer-review overseen by an excellent editor @TobiasGoris. Many thanks @DoroKretschmer@AndreasPeschel1@CoE_CMFI and everyone involved. Take a look: https://t.co/pJcvRglqPw
Tragically, as cases of whooping cough surge in England, @UKHSA reports that five precious infants have lost their lives to this disease.
@UKHSA figures show that 2,793 cases were reported by the end of March.
That compares to 858 cases for the whole of 2023.
Get the facts👇🏽
🆕Opportunity! We have an exciting opportunity for early career researchers to join our fellowship scheme, to help individuals to become future leaders in the fields of food, microbes &/or health research🔬
💷 £42,000 - £54,000
🗓️ Apply by 7 June 2024
➡️ https://t.co/LsTXKVnBm7
Bacteria on the International Space Station have mutated into opportunistic pathogens never seen on Earth: several strains of a multi-drug-resistant bacterium known as Enterobacter bugandensis
read more: https://t.co/CQxnek0o1T
At #TheUniversityofWarwick, we are developing an efficient platform for rapid diagnostics of urinary tract infections and associated antimicrobial resistance. Join our survey: https://t.co/XpM1RTWLbF
Help us make diagnostics better🌟
#UTI#AMR#diagnostics#rapidtest
Come check out Theo’s poster at A238 on our recently published work on commensal Neisseria OMVs as a platform to deliver meningococcal antigens to the immune system #Microbio24